Also, bortezomib induces p53-dependent apoptosis in MM cells, as it activates and stabilizes the tumour suppressor p53 protein via cleavage of the ubiquitin-ligation enzyme MDM2. The gene discussed is TP53; the disease is Miyoshi myopathy.